Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)
Phase 3
Completed
- Conditions
- Insomnia
- Registration Number
- NCT00095043
- Lead Sponsor
- H. Lundbeck A/S
- Brief Summary
The purpose of this trial is to study the safety of MK0928 on insomnia in the elderly.
- Detailed Description
The duration of treatment is 1 year.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 320
Inclusion Criteria
- Diagnosis of Insomnia
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Safety and tolerability after 12 months of treatment
- Secondary Outcome Measures
Name Time Method Discontinuation symptoms and rebound insomnia using sleep diary and Tyrer Withdrawal Symptom Questionnaire